The Pfizer Clinical Research Unit in New Haven is conducting a clinical trial of a combination of two study drugs for certain types of tumors associated with cancer. This part of the study will look at the effects of different oral forms of the study drug combination with or without food.
The study drugs in this trial are being evaluated together for the treatment of certain types of tumors associated with cancer. Millions of people are diagnosed with cancer every year. Affected patients need effective and safe treatments, and healthy volunteers are a vital part of developing these medicines.
Learn how you can help patients as a healthy volunteer below.
Who may participate
Clinical trials are key to developing potential life-changing treatments for people across the globe, and they wouldn’t be possible without participants.
This study is seeking healthy adult volunteers, meaning that the participants will not have the condition being studied and are in overall good health. In addition to the criteria listed, participants must meet the following requirements:
- Willing to take a study drug
- Willing and able to come to our facility in New Haven, CT*
- Willing and able to comply with all study procedures
*participants may be eligible to receive a bonus for travel, ask our staff for details
**female participants must be unable to bear children
There are other requirements for participation in this study. The study staff will explain these to you during the screening process.
Do you know someone who may meet these requirements? Refer a friend and you may be eligible to receive a bonus.
Condition
Healthy
Age
18-65 years
Sex
All sexes**
Referral bonus
Up to $100
Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.
What to expect
If this study may be a fit for you, you’ll be invited to a screening visit at our facility in New Haven, CT. If you qualify for the study, there may be a period of up to 28 days before dosing.
If you choose to participate, you will stay at our facility for 15 overnights. The morning after you check in, you will receive a single dose of both study drugs together without food. About 5 days later, you will receive another dose of both study drugs, again without food. Finally, after another 5 days, you will receive a third dose of both study drugs, this time after a high-fat breakfast. All doses will be provided as one or more tablets to swallow whole. The total amount of study drug you receive in each dose will be the same, however they may look different or include a different number of tablets.
Throughout the study, staff will closely monitor your health status and collect data, such as the levels of the study drug in your blood.
This study requires you to stay at the PCRU for the entire duration of each inpatient stay unless you choose to withdraw. You can learn more about what to expect during your participation by browsing our FAQ section.
Required overnight stays
15 consecutive overnights
Long-term follow up
1 phone call
How long is this study?
About 39 days
Compensation
Up to $6,850 upon completion of the study
All of the study procedures will be clearly explained to you during screening and can be viewed in the informed consent form.
We've updated the PCRU Loyalty Program!
We refreshed our Participant Loyalty Program with all-new unique tiered gifts for new and returning participants.
Interested in participating?
Complete and submit this form, and a Pfizer New Haven Clinical Research Unit (PCRU) representative will contact you.
You may also call 1-800-254-6398 and speak with a PCRU representative to learn more.
For Japanese language assistance only, please call 1-833-711-9984.
The personal data gathered here will be collected, processed, and maintained in a confidential manner. Your information will be stored in our research unit’s database. We may use this information to invite you to participate in current and future clinical studies at the PCRU. You will have full access to your records at the Pfizer New Haven Clinical Research Unit and the opportunity to correct them if necessary.